23-seleno-25-homotaurocholic acid has been researched along with allylamine in 1 studies
Studies (23-seleno-25-homotaurocholic acid) | Trials (23-seleno-25-homotaurocholic acid) | Recent Studies (post-2010) (23-seleno-25-homotaurocholic acid) | Studies (allylamine) | Trials (allylamine) | Recent Studies (post-2010) (allylamine) |
---|---|---|---|---|---|
147 | 8 | 42 | 734 | 112 | 217 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Johns, W; Lal, S; Leitao, E; McLaughlin, J; Orekoya, O; Paine, P | 1 |
1 other study(ies) available for 23-seleno-25-homotaurocholic acid and allylamine
Article | Year |
---|---|
Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Cholestyramine Resin; Colesevelam Hydrochloride; Colon; Diarrhea; Female; Humans; Male; Middle Aged; Retrospective Studies; Steatorrhea; Taurocholic Acid; Young Adult | 2015 |